Skip to main content
logo
Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.96
+0.57 (6.79%)
At close: Nov 6, 2026, 4:00 PM EST
9.11
+0.14 (1.62%)
After-hours: Nov 6, 2026, 7:45 PM EST

Helus Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
65524013331476142
Market Cap Growth
120.46%80.08%-57.56%314.56%-46.51%-13.35%
Enterprise Value
48845392855991
Last Close Price
8.964.806.3415.7114.6331.05

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
2.291.040.811.462.132.32
P/TBV Ratio
3.731.451.332.045.713.46

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
---0.00--
Net Debt / Equity Ratio
-0.69-0.68-0.57-0.71-0.34-0.70
Net Debt / EBITDA Ratio
1.001.100.912.660.320.84
Net Debt / FCF Ratio
1.181.181.303.030.351.18
Quick Ratio
9.768.386.5821.143.487.05
Current Ratio
10.979.527.7521.654.097.38
Return on Equity (ROE)
-86.94%-74.60%-44.34%-45.91%-76.36%-83.35%
Return on Assets (ROA)
-44.38%-41.35%-33.05%-27.69%-46.68%-45.29%
Return on Capital Employed (ROCE)
-69.00%-61.50%-62.50%-27.00%-106.80%-83.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-45.19%-61.62%-61.19%-18.35%-46.30%-38.23%
FCF Yield
-21.50%-55.57%-54.25%-16.20%-46.38%-25.61%
Buyback Yield / Dilution
-103.06%-72.10%-143.72%-70.04%-10.85%-67.27%
SEC Filings: 10-K · 10-Q